Documente Academic
Documente Profesional
Documente Cultură
Assi A.H, Khoury E.K, Dbouk H, Khalil E.L, Mouhieddine, El Saghir S.N. 2013.
Epidemiology and prognosis of breast cancer in young women. J Thoracic
Disease, vol 5:52-8
Bland KI, et al, 2007, The Breast. In: Schwartz (Editor) Schwartz’s Principles of
Surgery. Eight Edition. Graw Hill Inc, New York, p: 453-500
Clark GM, 1996. Prognostic and Predictive Factors. Dalam : Harris Jr, Lippmann
ME, Morrow M,Hellman S (eds). Diseases of the Breast. Philadelphia :
Lippincott-Raven :461-85.
Donegan W.L., Cancer of The Breast : Local And Regional Recurrence, 5th
edition, Saunders Co, 2002, 37:825-840.
80
Fitzgibbons PL, Page DL, Weaver D, Thor AD, Alfred DC, Clark GM, Ruby SG,
O’Mallery F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A,
Schnitt SJ, 2000. Prognostic factors in breast cancer. College of American
Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 966 –
978.
Gabriel and Domchek, 2010, Breast cancer in young women, Gabriel and
Domchek Breast Cancer Research, 12 : 212
Jardines L, Haffty BG, Doroshow JH, Fisher P, Weitzel , 2003. Breast cancer.
Dalam:Pazdur R, Cola LR, Hoskins WJ, Wagman LD (eds). Cancer
Management, A Multidiciplinary Approach. 2003 edition. The Oncology
Group, New York :163 -235.
Kopans DB, 2000. Imaging Analysis of Breast Lesions . Dalam : Harris JR,
Lippmann ME, Morrow M, Osborne CK(eds): Diseases of the Breas.
Second edition, Lippincott, Williams &Wilkins, Philadelphia: 123-148.
Li Jianyi, Jia S, Zhang W, Zhang Y, Fei X, Tian R. 2013. Survival Analysis Based
on Clinicophatological Data from a Single Institution: Chemotherapy
Intensity Would Be Enhanced in Patient with Positive Hormone Receptor
and Positive HER2 in China Who Cannot Afford the Target Therapy. ISRN
Oncology. Vol 2013: 8 pages.
81
Miremadi A and Pinder SE, 2002. Pathology and classification of breast
carcinoma. BCO, 5:1-7.
Moore KL, 2007, Breast. In:Essensial Clinicall Anatomy, Third Edition. Williams
& Walkins Baltimore, USA; p. 57 – 61
Park Y, et al, 2011, Current status of therapy for breast cancer worldwide and in
Japan, World J Clin Oncol 10; 2(2): 125-134
Singletary SE, Alfred C, Ashley P, Bassett LW, Berry D, Bland KI, Borgen PI,
Clark G, Edges SB, Hayes DF, Hughes LL, Hutter RVP, Morrow M, Page
DL, Recht A, Theriault RL, Thor A, Weaver DL, Wieand HS, Greence FL,
2002. Revision of the American Joint Committee on Cancer Staging System
for Breast Cancer. J Clin Oncol 20 :3628-3636.
Skye Hung et al, 2012, Late Recurrences in Luminal-Like Breast Cancer, Journal
Cancer Res Pract, Department of radiation oncology, Taipei, Taiwan.
Solorzano CC, Ahearne PM, Leach SD, Feigh BW, 2003, Invasive breast cancer.
Dalam: Feigh BW, Berger DH, Fuhrman GM (eds): The MD Anderson
82
Tanioka, et al, 2010, Predictor of recurrence in breast cancer patient with a
pathologic complete response after neoadjuvant chemotherapy, British
Journal of Cancer 103, 297-302.
Voogd AC, et al, 2001, Differences in Risk Faktors for Lokal and distant
recurrence after Breast Conserving Therapy or Mastectomy for Stage I and
II Breast Cancer : Pooled Result of Two Large European Randomized
Trials, Journal of Clinical Oncology , Vol 19, No 6 (March 15) : p 1688 –
169
83